Asked $250,000 for 7%
Christine Jurzenski of Lake Tahoe and Erica Schultz of San Diego pitched Cranel, a concentrated cranberry wellness shot for UTI prevention with the equivalent of 3,000 cranberries and 500 milligrams of proanthocyanidins per shot, sold in four-packs for about $15. Frustrated that existing cranberry products had too much sugar or too little active cranberry, they had raised $1.1 million from angels. Lifetime sales were $3.5 million, with $1.3 million in 2023, but the company spent about $500,000 a year on advertising and lost roughly $200,000. Lori Greiner would use it herself but questioned acquisition costs, Robert Herjavec worried about the marketing strategy, Fawn Weaver saw a high cost of educating customers, Daniel Lubetzky said it wasn't right for his portfolio, and Kevin O'Leary questioned the competitive landscape. None of the five made an offer.
“After the sharks winced at the shot's tartness, the founders answered: it's gross, it works. When Lori asked whether it treats an existing UTI, Erica told her to see a doctor, since Cranel is a preventative, not a cure.”
- Out
- Lori Greiner, Robert Herjavec, Fawn Weaver, Daniel Lubetzky, Kevin O'Leary
Where they are now:Thriving$2M revenueFull update →
Health & Wellness companies have a 59% deal rate on Shark Tank